Model deaths in disjoint equal-duration periods as independent observations with Poisson distributions with comparable population exposure and ascertainment. The expected before and after counts are and . Their difference has
The expected signal relative to its standard deviation is therefore
Under the null of equal rates, condition on : the first-period count has a binomial distribution with parameters and . At a total near 720, the two-sided 5% rejection boundary for is approximately . Under the proposed alternative, conditional on that total, its mean is and its variance is . Thus at the normal approximation gives power approximately
The lower-tail rejection probability is negligible at this alternative; allowing the Poisson total to fluctuate and using discrete rejection cutoffs changes the approximation slightly: an exact two-sided conditional test has about power under these Poisson means. Two years on each side should have adequate power for a 20% reduction under this model, though a particular realization can still fail to detect it.
This conclusion needs stable recording of drug-related deaths, comparable exposure denominators and no substantial overdispersion or temporal dependence. A change in population size, certification practice or other drug use can affect the comparison. Detecting a decline does not establish that mephedrone caused it: attributing displacement requires a credible comparison of potential outcomes, using an otherwise expected trend or other controls for changes occurring at the same time.

Articles by others on the same topic (0)

There are currently no matching articles.